Literature DB >> 33232666

The Power of Plasticity-Metabolic Regulation of Hepatic Stellate Cells.

Parth Trivedi1, Shuang Wang1, Scott L Friedman2.   

Abstract

Hepatic stellate cells (HSCs) are resident non-parenchymal liver pericytes whose plasticity enables them to regulate a remarkable range of physiologic and pathologic responses. To support their functions in health and disease, HSCs engage pathways regulating carbohydrate, mitochondrial, lipid, and retinoid homeostasis. In chronic liver injury, HSCs drive hepatic fibrosis and are implicated in inflammation and cancer. To do so, the cells activate, or transdifferentiate, from a quiescent state into proliferative, motile myofibroblasts that secrete extracellular matrix, which demands rapid adaptation to meet a heightened energy need. Adaptations include reprogramming of central carbon metabolism, enhanced mitochondrial number and activity, endoplasmic reticulum stress, and liberation of free fatty acids through autophagy-dependent hydrolysis of retinyl esters that are stored in cytoplasmic droplets. As an archetype for pericytes in other tissues, recognition of the HSC's metabolic drivers and vulnerabilities offer the potential to target these pathways therapeutically to enhance parenchymal growth and modulate repair.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 33232666      PMCID: PMC7858232          DOI: 10.1016/j.cmet.2020.10.026

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  190 in total

1.  Adipogenic phenotype of hepatic stellate cells.

Authors:  Hide Tsukamoto
Journal:  Alcohol Clin Exp Res       Date:  2005-11       Impact factor: 3.455

2.  Retinol mobilization from cultured rat hepatic stellate cells does not require retinol binding protein synthesis and secretion.

Authors:  P Sauvant; V Sapin; M C Alexandre-Gouabau; I Dodeman; S Delpal; L Quadro; A Partier; A Abergel; V Colantuoni; E Rock; V Azaïs-Braesco
Journal:  Int J Biochem Cell Biol       Date:  2001-10       Impact factor: 5.085

Review 3.  Retinoic acids and hepatic stellate cells in liver disease.

Authors:  Young-Sun Lee; Won-Il Jeong
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

4.  Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner.

Authors:  Guoping Jiang; Horng-Ren Yang; Lianfu Wang; Gary M Wildey; John Fung; Shiguang Qian; Lina Lu
Journal:  Transplantation       Date:  2008-12-15       Impact factor: 4.939

5.  Retinol release by activated rat hepatic lipocytes: regulation by Kupffer cell-conditioned medium and PDGF.

Authors:  S L Friedman; S Wei; W S Blaner
Journal:  Am J Physiol       Date:  1993-05

6.  Mitochondrial reactive oxygen species regulate transforming growth factor-β signaling.

Authors:  Manu Jain; Stephanie Rivera; Elena A Monclus; Lauren Synenki; Aaron Zirk; James Eisenbart; Carol Feghali-Bostwick; Gokhan M Mutlu; G R Scott Budinger; Navdeep S Chandel
Journal:  J Biol Chem       Date:  2012-11-30       Impact factor: 5.157

7.  Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development.

Authors:  Kinji Asahina; Shirley Y Tsai; Peng Li; Mamoru Ishii; Robert E Maxson; Henry M Sucov; Hidekazu Tsukamoto
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

8.  Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids.

Authors:  G Allenby; M T Bocquel; M Saunders; S Kazmer; J Speck; M Rosenberger; A Lovey; P Kastner; J F Grippo; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

9.  The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through Autophagy.

Authors:  Rosa S Kim; Daisuke Hasegawa; Nicolas Goossens; Takuma Tsuchida; Varinder Athwal; Xiaochen Sun; Christopher L Robinson; Dipankar Bhattacharya; Hsin-I Chou; David Y Zhang; Bryan C Fuchs; Youngmin Lee; Yujin Hoshida; Scott L Friedman
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

Review 10.  Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis.

Authors:  Prakash Ramachandran; Kylie P Matchett; Ross Dobie; John R Wilson-Kanamori; Neil C Henderson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06-01       Impact factor: 46.802

View more
  22 in total

1.  Extracellular Vesicles from miR-148a-5p-Enriched Bone Marrow Mesenchymal Stem Cells Relieve Hepatic Fibrosis by Targeting Smad4.

Authors:  Ji Xuan; Huabin Xu; Hui Li; Desheng Chen; Yuping Qiu; Xi Chen; Mei Shao; Xianming Xia
Journal:  Mol Biotechnol       Date:  2022-01-10       Impact factor: 2.695

2.  Therapeutic Effects of Salvianolic Acid B on Angiotensin II-Induced Atrial Fibrosis by Regulating Atrium Metabolism via Targeting AMPK/FoxO1/miR-148a-3p Axis.

Authors:  Jie Liu; Qijuan Sun; Xiaotong Sun; Qian Wang; Guangchen Zou; Dewei Wang; Baoxiang Zhuang; Zhaodong Juan; Rui Zhang; Daoliang Zhang
Journal:  J Cardiovasc Transl Res       Date:  2022-08-19       Impact factor: 3.216

3.  Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation.

Authors:  Ren Guo; Xiaohui Jia; Zhenbin Ding; Gang Wang; Mengmeng Jiang; Bing Li; Shanshan Chen; Bingqing Xia; Qing Zhang; Jian Liu; Ruting Zheng; Zhaobing Gao; Xin Xie
Journal:  Theranostics       Date:  2022-07-04       Impact factor: 11.600

4.  Targeting oxidized phospholipids by AAV-based gene therapy in mice with established hepatic steatosis prevents progression to fibrosis.

Authors:  Clint M Upchurch; Scott Yeudall; Caitlin M Pavelec; Dennis Merk; Jan Greulich; Mohan Manjegowda; Shyam S Raghavan; Irina M Bochkis; Michael M Scott; Edward Perez-Reyes; Norbert Leitinger
Journal:  Sci Adv       Date:  2022-07-15       Impact factor: 14.957

5.  Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1.

Authors:  Piao Luo; Dandan Liu; Qian Zhang; Fan Yang; Yin-Kwan Wong; Fei Xia; Junzhe Zhang; Jiayun Chen; Ya Tian; Chuanbin Yang; Lingyun Dai; Han-Ming Shen; Jigang Wang
Journal:  Acta Pharm Sin B       Date:  2021-12-18       Impact factor: 14.903

Review 6.  Hepatic stellate cells in physiology and pathology.

Authors:  Dakota R Kamm; Kyle S McCommis
Journal:  J Physiol       Date:  2022-03-30       Impact factor: 6.228

Review 7.  Inflammatory and fibrotic mechanisms in NAFLD-Implications for new treatment strategies.

Authors:  Youngmin A Lee; Scott L Friedman
Journal:  J Intern Med       Date:  2021-09-26       Impact factor: 8.989

Review 8.  Liver X receptors and liver physiology.

Authors:  Lillian Russo-Savage; Ira G Schulman
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-03-11       Impact factor: 6.633

Review 9.  The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis.

Authors:  Jingjing Li; Chuanyong Guo; Jianye Wu
Journal:  Drug Des Devel Ther       Date:  2021-06-18       Impact factor: 4.162

10.  Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells.

Authors:  Qiu-Ju Han; Yong-Liang Mu; Hua-Jun Zhao; Rong-Rong Zhao; Quan-Juan Guo; Yu-Hang Su; Jian Zhang
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.